Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bisphenol A safe?

This article was originally published in The Tan Sheet

Executive Summary

Results of National Toxicology Program research prompt Michigan Democrats John Dingell, chairman of the House Energy and Commerce Committee, and Bart Stupak, Oversight and Investigations Subcommittee, to ask FDA to reconsider the safety of the chemical bisphenol A in products intended for use by infants and children. In an April 14 draft brief, the NTP concludes there is "some concern for neural and behavioral effects in fetuses, infants, and children at current human exposures" and "the possibility that bisphenol A may alter human development cannot be dismissed." Stupak says FDA relied on two industry-funded studies to determine the chemical's safety while other authorities "used all available data to reach vastly different conclusions"...

You may also be interested in...



FDA says BPA exposure is safe

FDA concludes the current levels of bisphenol A - a chemical in the container liners of prepared liquid infant formula - that transfer to foods and are absorbed by children are "safe," according to a draft report released Aug. 14. Based on published risk assessments, the agency estimates BPA exposure from food contact materials in infants is less than half the established level for no observed adverse effect. Some scientists, physicians and children's health advocates "expressed outrage" with the agency's conclusion, according to a release from the Center for Health Environment and Justice. Dissenters say FDA relies on two studies funded by the American Chemical Council and ignores dozens of other studies that highlight risks. FDA, however, says that limits in study design and data quality are insufficient to lower the current NOAEL for BPA. Michigan Democrats John Dingell, chairman of the House Energy and Commerce Committee and Oversight and Investigations Subcommittee Bart Stupak asked FDA to reconsider BPA safety in infant formulas in April (1"The Tan Sheet" April 21, 2008, In Brief)

FDA chief scientist wants BPA review

At the request of newly appointed FDA Chief Scientist Frank M. Torti, a new Science Board subcommittee will hold a public meeting on the safety of bisphenol-A in plastics, review an FDA Task Force report on BPA and deliver its findings to the Science Board's annual meeting in the fall, according to a June 6 FDA release. The Task Force will make recommendations to Commissioner Andrew von Eschenbach following its review. Michigan Democrats John Dingell, chairman of the House Energy and Commerce Committee, and Oversight and Investigations Subcommittee Chairman Bart Stupak in April asked FDA to reconsider BPA's safety in infant products (1"The Tan Sheet" April 12, 2008, In Brief)...

Dingell, Stupak ask firms to remove BPA

Michigan Democrats John Dingell, chairman of the House Energy and Commerce Committee, and Oversight and Investigations Subcommittee Chairman Bart Stupak ask infant formula makers Abbott, Mead Johnson, Nestle and PBM to voluntarily remove the chemical bisphenol A from their infant formula packaging. Dingell and Stupak in April asked FDA to reconsider BPA's safety in infant products (1"The Tan Sheet" April 12, 2008, In Brief). "We believe this measure will help protect developing infants and children from the neural, behavioral and developmental risks of BPA" and provide reassurance to concerned parents, the congressmen say in their May 6 letter to the firms. The lawmakers ask the companies to respond in writing to their letter and deliver a response to subcommittee no later than May 20...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101565

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel